[144] Exact Sciences Corp SEC Filing

Rhea-AI Filing Summary

Exact Sciences (EXAS) submitted a Form 144 notifying a proposed sale of 1,485 shares of common stock through Fidelity Brokerage Services LLC (900 Salem Street, Smithfield, RI 02917) with an aggregate market value of $62,399.70. The securities were acquired on 06/12/2025 by restricted stock vesting and payment is listed as compensation. The approximate date of sale is reported as 08/13/2025, and the filing states there were no securities sold during the past three months by the person for whose account the sale is proposed. The filing also discloses total shares outstanding of 189,319,110 and includes the standard representation that the filer does not know of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for vested compensation; size appears de minimis versus outstanding shares.

The Form 144 reports a proposed sale of 1,485 common shares with an aggregate market value of $62,399.70, acquired by restricted stock vesting on 06/12/2025. The broker is Fidelity Brokerage Services LLC and the approximate sale date is 08/13/2025. The filing states 189,319,110 shares outstanding and notes no sales in the past three months by the reporting person. Impact assessment: not impactful for investors given the small absolute size and routine compensation origin of the shares.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 mechanics and includes the standard representation on material non-public information.

The notice documents that the shares arose from restricted stock vesting and lists payment as compensation, which aligns with routine insider equity compensation practices. The form reiterates the filers representation that they do not know of any undisclosed material adverse information and references Rule 10b5-1 language for plan adoption or trading instructions. From a governance perspective, the filing is a standard compliance disclosure with no indications of governance or disclosure lapses within the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1485	62399.70	189319110	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2025	Restricted Stock Vesting	Issuer			1485	06/12/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Exact Sciences' (EXAS) Form 144 report?

The Form 144 reports a proposed sale of 1,485 common shares acquired by restricted stock vesting, with an aggregate market value of $62,399.70.

Who is the broker handling the proposed sale in EXAS Form 144?

The broker listed is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

When were the shares acquired and what is the approximate sale date listed?

The shares were acquired on 06/12/2025 through restricted stock vesting, and the approximate date of sale is 08/13/2025.

Does the filing report any securities sold in the past three months by the filer?

No. The Form 144 explicitly states Nothing to Report for securities sold during the past three months.

How many shares outstanding does the filing disclose?

The filing discloses 189,319,110 shares outstanding.

What does the filer represent about material non-public information?

By signing, the filer represents they do not know of any material adverse information